Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2023	May 01, 2022
Cash flows from operating activities:
Net income	$ 88,223	$ 74,755
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	39,085	41,405
Share-based compensation	3,830	3,041
Changes in assets and liabilities:
Accounts receivable	(5,952)	(25,122)
Inventories	(1,905)	(5,081)
Other current assets	1,382	(10,858)
Accounts payable, accrued liabilities, and other	(14,986)	25,149
Net cash provided by operating activities	109,677	103,289
Cash flows from investing activities:
Purchases of property, plant and equipment	(57,728)	(34,809)
Purchases of available-for-sale debt securities	(9,837)	0
Proceeds from maturities of available-for-sale debt securities	4,000	0
Government incentives	1,393	1,394
Other	(88)	(199)
Net cash used in investing activities	(62,260)	(33,614)
Cash flows from financing activities:
Repayments of debt	(14,720)	(27,571)
Purchases of treasury stock	0	(2,522)
Contribution from noncontrolling interest	0	24,995
Proceeds from share-based arrangements	730	4,384
Net settlements of restricted stock awards	(1,252)	(1,452)
Net cash used in financing activities	(15,242)	(2,166)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	15,621	(14,917)
Net increase in cash, cash equivalents, and restricted cash	47,796	52,592
Cash, cash equivalents, and restricted cash at beginning of period	322,409	279,680
Cash, cash equivalents, and restricted cash at end of period	370,205	332,272
Less: Ending restricted cash	2,720	2,990
Cash and cash equivalents at end of period	367,485	329,282
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 14,420	$ 5,737